Literature DB >> 15027694

[Peripheral neuropathy rehabilitation. Indications for a diagnostic-rehabilitation approach].

R Casale1, A La Manna, S Salvini, M Maini, F Ceccherelli, G Frazzitta.   

Abstract

The increased incidence of occupational neurological disorders has led, in recent years, to the development of new specialties in neurorehabilitation for the recovery of deficits of central nervous system (CNS) lesions. This same development has not occurred for damage to the peripheral nervous system (PNS), the treatment of which is still based on empirically applied rehabilitation techniques. This is due to the fact that the peripheral neuropathies comprise a vast groups of disorders caused by a huge variety of etiological agents; in order to identify their exact cause and thus be able to differentiate rehabilitation techniques it is necessary to classify them. The aim of this study is to summarize the main rehabilitation strategies, pharmacological treatments and surgical techniques used most effectively in the management of peripheral neuropathies in order to develop a therapeutic rehabilitation strategy for each of the different forms and lay the bases for the development of specific guidelines.

Entities:  

Mesh:

Year:  2003        PMID: 15027694

Source DB:  PubMed          Journal:  G Ital Med Lav Ergon        ISSN: 1592-7830


  2 in total

Review 1.  Neuropathic Pain and Rehabilitation: A Systematic Review of International Guidelines.

Authors:  Andrea Bernetti; Francesco Agostini; Alessandro de Sire; Massimiliano Mangone; Lucrezia Tognolo; Annalisa Di Cesare; Pierangela Ruiu; Teresa Paolucci; Marco Invernizzi; Marco Paoloni
Journal:  Diagnostics (Basel)       Date:  2021-01-05

2.  Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children.

Authors:  Luisa Santangelo; Giuseppe Stefano Netti; Elena Ranieri; Mario Giordano; Diletta Domenica Torres; Giovanni Piscopo; Vincenza Carbone; Luciana Losito; Leonardo Milella; Maria Luigia Lasorella; Pasquale Conti; Delio Gagliardi; Maria Chironna; Federica Spadaccino; Elena Bresin; Antonio Trabacca
Journal:  Ital J Pediatr       Date:  2021-09-06       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.